Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In this randomized trial comparing cisplatin plus gemcitabine with gemcitabine alone for the treatment of biliary tract cancer, overall survival and progression-free survival were improved with the use of cisplatin plus gemcitabine. Adverse events were similar in the two groups.
In this trial comparing cisplatin plus gemcitabine with gemcitabine...
Alternative Titles
Full title
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_223926667
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_223926667
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa0908721
